Skip to main content
Top
Published in: Obesity Surgery 11/2012

01-11-2012 | Animal Research

The Deleterious Effect of Bariatric Surgery on Cortical and Trabecular Bone Density in the Femurs of Non-obese, Type 2 Diabetic Goto-Kakizaki Rats

Authors: José Luis Pérez-Castrillón, José Antonio Riancho, Daniel de Luis, José Ramón Caeiro, David Guede, Manuel González-Sagrado, Marta Ruiz-Mambrilla, María Domingo-Andrés, Rosa Conde, David Primo-Martín

Published in: Obesity Surgery | Issue 11/2012

Login to get access

Abstract

Background

The effects of type 2 diabetes on bone mass and microstructure are not clear. The aim of this study was to evaluate bone microstructural properties and volumetric bone mineral density (vBMD) in type 2 diabetic Goto-Kakizaki non-obese rats after gastrojejunal bypass and their relationship with hormonal parameters.

Methods

We designed an experimental study in Goto-Kakizaki rats with and without gastrojejunal bypass, performing densitometric and microstructural studies of the distal femur using X-ray computed microtomography (micro-CT). Levels of insulin, glucagon, leptin, and glucagon-like peptide-1 (GLP-1) were also determined.

Results

We observed reduced cortical (1,488.92 ± 98.2 vs. 1,727.92 ± 133.45 mg/cm3, p = 0.028) and trabecular (180.8 ± 9 vs. 261.23 ± 45.54 mg/cm3, p = 0.036) vBMD in operated rats. Bone volume fraction (BV/TV) and trabecular connectivity were reduced in operated rats, while there was a reduction in cortical thickness and an increase in rod-like trabeculae at the expense of plate-like trabeculae. Leptin was reduced (1,042 ± 549 vs. 2,447 ± 1,035 pg/ml, p = 0.05) and GLP-1 increased (1.62 ± 0.32 vs. 0.96 ± 0.1 ng/ml, p = 0.008) but only leptin showed a significant association with vBMD

Conclusions

In type 2 diabetic Goto-Kakizaki rats, gastrojejunal bypass produces a reduction in cortical and trabecular bone mineral density and a deterioration in bone quality that could be explained, in part, by the reduction in leptin levels.
Literature
1.
go back to reference Olmos JM, Pérez Castrillón JL, García MT, et al. Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus. Bone Miner. 1994;26:1–8.PubMedCrossRef Olmos JM, Pérez Castrillón JL, García MT, et al. Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus. Bone Miner. 1994;26:1–8.PubMedCrossRef
2.
go back to reference Carnevale V, Romagnoli E, D’Erasmo E. Skeletal involvement in patients with diabetes mellitus. Diabetes Metab Res Rev. 2004;20:196–204.PubMedCrossRef Carnevale V, Romagnoli E, D’Erasmo E. Skeletal involvement in patients with diabetes mellitus. Diabetes Metab Res Rev. 2004;20:196–204.PubMedCrossRef
3.
go back to reference Cortés Sancho R, Pérez Castrillón JL, Martín Escudero JC, et al. Type 2 diabetes mellitus as a risk factor for hip fracture. J Am Geriatr Soc. 2004;52:1778–9.PubMedCrossRef Cortés Sancho R, Pérez Castrillón JL, Martín Escudero JC, et al. Type 2 diabetes mellitus as a risk factor for hip fracture. J Am Geriatr Soc. 2004;52:1778–9.PubMedCrossRef
4.
go back to reference De Liefde II, Van der KM, De Laet CE, et al. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int. 2005;16:1713–20.PubMedCrossRef De Liefde II, Van der KM, De Laet CE, et al. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int. 2005;16:1713–20.PubMedCrossRef
5.
go back to reference Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005;48:1292–9.PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005;48:1292–9.PubMedCrossRef
6.
go back to reference Janghorbeni M, Van Dam RM, Willet L, et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166:495–505.CrossRef Janghorbeni M, Van Dam RM, Willet L, et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166:495–505.CrossRef
7.
go back to reference Buchwald H, Avidar Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef Buchwald H, Avidar Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef
8.
go back to reference Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.PubMedCrossRef Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.PubMedCrossRef
9.
go back to reference Pacheco D, De Luis DA, Romero A, et al. The effects of duodenal–jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg. 2007;194:221–4.PubMedCrossRef Pacheco D, De Luis DA, Romero A, et al. The effects of duodenal–jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg. 2007;194:221–4.PubMedCrossRef
10.
go back to reference Zhang L, Liu Y, Wang D, et al. Bone biomechanical and histomorphometrical investment in type 2 diabetic Goto-Kakizaki rats. Acta Diabetol. 2009;46:119–26.PubMedCrossRef Zhang L, Liu Y, Wang D, et al. Bone biomechanical and histomorphometrical investment in type 2 diabetic Goto-Kakizaki rats. Acta Diabetol. 2009;46:119–26.PubMedCrossRef
11.
go back to reference Feldkamp LA, Davis LC, Kress JW. Practical cone-beam algorithm. J Opt Soc Am. 1984;A6:612–9.CrossRef Feldkamp LA, Davis LC, Kress JW. Practical cone-beam algorithm. J Opt Soc Am. 1984;A6:612–9.CrossRef
12.
go back to reference Xuan L, Sasov A. Cluster reconstruction strategies for micro CT and nano Ct scanners. In: Proceedings of the fully three-dimensional image reconstruction meeting in radiology and nuclear medicine, July 6–9, 2005, Salt Lake City Xuan L, Sasov A. Cluster reconstruction strategies for micro CT and nano Ct scanners. In: Proceedings of the fully three-dimensional image reconstruction meeting in radiology and nuclear medicine, July 6–9, 2005, Salt Lake City
13.
go back to reference Hildebrand T, Rüegsegger P. A new method for the model independent assessment of thickness in three-dimensional images. J Microsc. 1997;185:67–75.CrossRef Hildebrand T, Rüegsegger P. A new method for the model independent assessment of thickness in three-dimensional images. J Microsc. 1997;185:67–75.CrossRef
14.
go back to reference Ulrich D, van Rietbergen B, Laib A, et al. The ability of three dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone. 1999;25:55–60.PubMedCrossRef Ulrich D, van Rietbergen B, Laib A, et al. The ability of three dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone. 1999;25:55–60.PubMedCrossRef
15.
go back to reference Hildebrand T, Rüegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Eng. 1997;1:15–23.CrossRef Hildebrand T, Rüegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Eng. 1997;1:15–23.CrossRef
16.
go back to reference Hahn M, Vogel M, Pompesius-Kempa M, et al. Trabecular bone pattern factor: a new parameter for simple quantification of bone microarchitecture. Bone. 1992;13:327–30.PubMedCrossRef Hahn M, Vogel M, Pompesius-Kempa M, et al. Trabecular bone pattern factor: a new parameter for simple quantification of bone microarchitecture. Bone. 1992;13:327–30.PubMedCrossRef
17.
go back to reference Ott M, Fanti P, Malluche HH, et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg. 1992;2:341–8.PubMedCrossRef Ott M, Fanti P, Malluche HH, et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg. 1992;2:341–8.PubMedCrossRef
18.
go back to reference Berarducci A, Haines K, Murr MM. Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. Appl Nurs Res. 2009;22:35–41.PubMedCrossRef Berarducci A, Haines K, Murr MM. Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. Appl Nurs Res. 2009;22:35–41.PubMedCrossRef
19.
go back to reference Nuche B, Portal S, Moreno P, et al. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the camp-linked GLP-1 receptor. J Cell Physiol. 2010;225:585–92.CrossRef Nuche B, Portal S, Moreno P, et al. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the camp-linked GLP-1 receptor. J Cell Physiol. 2010;225:585–92.CrossRef
20.
go back to reference Nuche B, Moreno P, Esbrit P, et al. Effect of GLP-1 treatment on bone turnover in normal, type diabetic and insulin-resistant states. Calcif Tissue Int. 2009;84:453–61.CrossRef Nuche B, Moreno P, Esbrit P, et al. Effect of GLP-1 treatment on bone turnover in normal, type diabetic and insulin-resistant states. Calcif Tissue Int. 2009;84:453–61.CrossRef
21.
go back to reference Pacheco-Pantoja EL, Ranganath LR, Gallagher JA, et al. Receptors and effects of gut hormones in three osteoblastic cell lines. BMC Physiol. 2011;11:12.PubMedCrossRef Pacheco-Pantoja EL, Ranganath LR, Gallagher JA, et al. Receptors and effects of gut hormones in three osteoblastic cell lines. BMC Physiol. 2011;11:12.PubMedCrossRef
22.
go back to reference Thomas T, Gori F, Khosla S, et al. Leptin acts on human marrow stromal cell to enhance differentiation to osteoblast and to inhibit differentiation to adipocytes. Endocrinology. 1999;140:1630–1638.PubMedCrossRef Thomas T, Gori F, Khosla S, et al. Leptin acts on human marrow stromal cell to enhance differentiation to osteoblast and to inhibit differentiation to adipocytes. Endocrinology. 1999;140:1630–1638.PubMedCrossRef
24.
go back to reference Vasilkova O, Mokhort T, Sharshakova T, et al. Leptin is an independent determinant of bone mineral density in men with type 2 diabetes mellitus. Acta Diabetol. 2011. doi:10.1007/s00592-011-0266-0. Vasilkova O, Mokhort T, Sharshakova T, et al. Leptin is an independent determinant of bone mineral density in men with type 2 diabetes mellitus. Acta Diabetol. 2011. doi:10.​1007/​s00592-011-0266-0.
Metadata
Title
The Deleterious Effect of Bariatric Surgery on Cortical and Trabecular Bone Density in the Femurs of Non-obese, Type 2 Diabetic Goto-Kakizaki Rats
Authors
José Luis Pérez-Castrillón
José Antonio Riancho
Daniel de Luis
José Ramón Caeiro
David Guede
Manuel González-Sagrado
Marta Ruiz-Mambrilla
María Domingo-Andrés
Rosa Conde
David Primo-Martín
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 11/2012
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-012-0732-y

Other articles of this Issue 11/2012

Obesity Surgery 11/2012 Go to the issue